By Peter Brailey | Sunday 30 August 2020
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I wrote about Synairgen (SNG) back in July, and in doing so earned the dubious ticker from Tom Winnifrith as a “ramper” and the honour of a Special Bearcast as a response. The ticker amused me greater and I freely admit I agreed with 95% of Tom’s commentary on how to value a drugs company. However I see a “special situation” with this company’s SNG001 potential Covid treatment that may break the normal valuation rule set.
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Time left: 01:47:28